Canada Mirna Sequencing And Assay Market Size & Outlook
Canada mirna sequencing and assay market, 2018-2030 (US$M)
Related Markets
Canada mirna sequencing and assay market highlights
- The Canada mirna sequencing and assay market generated a revenue of USD 26.8 million in 2023 and is expected to reach USD 57.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Mirna sequencing and assay market data book summary
| Market revenue in 2023 | USD 26.8 million |
| Market revenue in 2030 | USD 57.8 million |
| Growth rate | 11.6% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
Other key industry trends
- In terms of revenue, Canada accounted for 7.8% of the global mirna sequencing and assay market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. mirna sequencing and assay market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 300.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MiRNA Sequencing And Assay Market Scope
MiRNA Sequencing And Assay Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada mirna sequencing and assay market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.6% in 2023. Horizon Databook has segmented the Canada mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The miRNA sequencing and assay market in Canada is likely to grow at a substantial rate owing to the increase in government initiatives to boost medical research in the country. Genome Canada is a government-funded nonprofit organization.
This organization is taking initiatives for development and application of genomics & genomic-based technologies to create social as well as economic benefits for Canadians. Major players in Canada are present through subsidiaries, regional distribution offices, or manufacturing plants.
However, innovative players such as Norgen Biotek Corp. and Canadian Center for Computational Genomics (C3G) have headquarters in Canada. In addition, in November 2018, Norgen Biotek Corp. achieved the Illumina Propel Certification as a Service Provider for Next-Generation Sequencing (NGS).
Reasons to subscribe to Canada mirna sequencing and assay market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada mirna sequencing and assay market databook
-
Our clientele includes a mix of mirna sequencing and assay market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into Canada mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada mirna sequencing and assay market size, by product & service, 2018-2030 (US$M)
Canada MiRNA Sequencing And Assay Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
